- Featured Product
- KD/KO Validated
Cyclin B2 Monoklonaler Antikörper
Cyclin B2 Monoklonal Antikörper für WB, IHC, IF/ICC, IF-P, Indirect ELISA
Wirt / Isotyp
Maus / IgG2a
Getestete Reaktivität
human, Maus
Anwendung
WB, IHC, IF/ICC, IF-P, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
2G8B7
Kat-Nr. : 67726-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
67726-1-PBS bindet in WB, IHC, IF/ICC, IF-P, Indirect ELISA Cyclin B2 und zeigt Reaktivität mit human, Maus
Getestete Reaktivität | human, Maus |
Wirt / Isotyp | Maus / IgG2a |
Klonalität | Monoklonal |
Typ | Antikörper |
Immunogen | Cyclin B2 fusion protein Ag16329 |
Vollständiger Name | cyclin B2 |
Berechnetes Molekulargewicht | 398 aa, 45 kDa |
Beobachtetes Molekulargewicht | 45 kDa |
GenBank-Zugangsnummer | BC105086 |
Gene symbol | Cyclin B2 |
Gene ID (NCBI) | 9133 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein-A-Reinigung |
Lagerungspuffer | PBS only |
Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Cyclin B2 (CCNB2) is a member of cyclin family proteins, which regulate the activities of cyclin dependent kinases (CDKs) and different cyclins function spatially and temporally in specific phases of the cell cycle. Cyclin B2 serves a key role in progression of G2/M transition. Cyclin B2 has been found to be up-regulated in a variety of human cancers, such as adrenocortical carcinoma, breast carcinoma, colorectal adenocarcinoma, pituitary adenoma and gastric cancer. The aberrant expression of Cyclin B2 deregulates spindle checkpoints in the cell cycle and results in chromosomal instability (CIN), one of the signature phenotypes of most cancers. Moreover, serum circulating Cyclin B2 mRNA expression has been found increased in cancer patients and associated with cancer stage and metastasis status.